Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2021

01-08-2021 | Coronary Heart Disease | Original Article

Effects of cardiac rehabilitation with and without meditation on myocardial blood flow using quantitative positron emission tomography: A pilot study

Authors: Sabahat Bokhari, MD, FACC, Robert H. Schneider, MD, FACC, John W. Salerno, PhD, Maxwell V. Rainforth, PhD, Carolyn Gaylord-King, PhD, Sanford I. Nidich, EdD

Published in: Journal of Nuclear Cardiology | Issue 4/2021

Login to get access

Abstract

Background

Psychosocial stress is recognized as a risk factor for coronary heart disease (CHD). High rates of CHD in African-Americans may be related to psychosocial stress. However, standard cardiac rehabilitation (CR) usually does not include a systematic stress-reduction technique. Previous studies suggest that the Transcendental Meditation (TM) technique may reduce CHD risk factors and clinical events. This pilot study explored the effects of standard CR with and without TM on a measure of CHD in African-American patients.

Methods

Fifty-six CHD patients were assigned to CR, CR + TM, TM alone, or usual care. Testing was done at baseline and after 12 weeks. The primary outcome was myocardial flow reserve (MFR) assessed by 13N-ammonia positron emission tomography (PET). Secondary outcomes were CHD risk factors. Based on guidelines for analysis of small pilot studies, data were analyzed for effect size (ES).

Results

For 37 patients who completed posttesting, there were MFR improvements in the CR + TM group (+20.7%; ES = 0.64) and the TM group alone (+12.8%; ES = 0.36). By comparison, the CR-alone and usual care groups showed modest changes (+ 5.8%; ES = 0.17 and − 10.3%; ES = − 0.31), respectively. For the combined TM group, MFR increased (+ 14%, ES = 0.56) compared to the combined non-TM group (− 2.0%, ES = − 0.08).

Conclusions

These pilot data suggest that adding the TM technique to standard cardiac rehabilitation or using TM alone may improve the myocardial flow reserve in African-American CHD patients. These results may be applied to the design of controlled clinical trials to definitively test these effects.

Trial registration

ClinicalTrials.gov registration # NCT01810029.
Appendix
Available only for authorised users
Literature
1.
go back to reference Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007;115(20):2675-82.PubMedCrossRef Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007;115(20):2675-82.PubMedCrossRef
2.
go back to reference Mead H, Ramos C, Grantham SC. Drivers of racial and ethnic disparities in cardiac rehabilitation use: Patient and provider perspectives. Med Care Res Rev 2016;73(3):251-82.PubMedCrossRef Mead H, Ramos C, Grantham SC. Drivers of racial and ethnic disparities in cardiac rehabilitation use: Patient and provider perspectives. Med Care Res Rev 2016;73(3):251-82.PubMedCrossRef
3.
go back to reference Midence L, Mola A, Terzic CM, et al. Ethnocultural diversity in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2014;34(6):437-44.PubMedCrossRef Midence L, Mola A, Terzic CM, et al. Ethnocultural diversity in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2014;34(6):437-44.PubMedCrossRef
4.
go back to reference Anderson L, Oldridge N, Thompson DR, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 2016;67(1):1-12.PubMedCrossRef Anderson L, Oldridge N, Thompson DR, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 2016;67(1):1-12.PubMedCrossRef
5.
go back to reference Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol 2005;45(5):637-51.PubMedCrossRef Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol 2005;45(5):637-51.PubMedCrossRef
6.
go back to reference Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364(9438):937-52.PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364(9438):937-52.PubMedCrossRef
7.
go back to reference Ford CD, Sims M, Higginbotham JC, et al. Psychosocial factors are associated with blood pressure progression among african americans in the jackson heart study. Am J Hypertens 2016;29(8):913-24.PubMedPubMedCentralCrossRef Ford CD, Sims M, Higginbotham JC, et al. Psychosocial factors are associated with blood pressure progression among african americans in the jackson heart study. Am J Hypertens 2016;29(8):913-24.PubMedPubMedCentralCrossRef
8.
go back to reference Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation 2005;111(10):1233-41.PubMedCrossRef Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation 2005;111(10):1233-41.PubMedCrossRef
9.
go back to reference Rainforth M, Schneider R, Nidich S, et al. Stress reduction programs in patients with elevated blood pressure: A systematic review and meta-analysis. Curr Hypertens Rep 2007;9(6):520-8.PubMedPubMedCentralCrossRef Rainforth M, Schneider R, Nidich S, et al. Stress reduction programs in patients with elevated blood pressure: A systematic review and meta-analysis. Curr Hypertens Rep 2007;9(6):520-8.PubMedPubMedCentralCrossRef
10.
go back to reference Bai Z, Chang J, Chen C, et al. Investigating the effect of transcendental meditation on blood pressure: A systematic review and meta-analysis. J Hum Hypertens 2015;29:653.PubMedCrossRef Bai Z, Chang J, Chen C, et al. Investigating the effect of transcendental meditation on blood pressure: A systematic review and meta-analysis. J Hum Hypertens 2015;29:653.PubMedCrossRef
11.
go back to reference Paul-Labrador M, Polk D, Dwyer J, et al. Effects of a randomized controlled trial of Transcendental Meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006;166:1218-24.PubMedCrossRef Paul-Labrador M, Polk D, Dwyer J, et al. Effects of a randomized controlled trial of Transcendental Meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006;166:1218-24.PubMedCrossRef
12.
go back to reference Orme-Johnson DW, Barnes VA, Schneider R. Transcendental Meditation for primary and secondary prevention of coronary heart disease. In: Allan R, Fisher J, editors. Heart & mind: The practice of cardiac psychology. 2nd ed. Washington, DC: American Psychological Association; 2012. p. 365-79. Orme-Johnson DW, Barnes VA, Schneider R. Transcendental Meditation for primary and secondary prevention of coronary heart disease. In: Allan R, Fisher J, editors. Heart & mind: The practice of cardiac psychology. 2nd ed. Washington, DC: American Psychological Association; 2012. p. 365-79.
13.
go back to reference Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000;31:568-73.PubMedCrossRef Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000;31:568-73.PubMedCrossRef
14.
go back to reference Schneider RH, Alexander CN, Staggers F, et al. Long-term effects of stress reduction on mortality in persons > 55 years of age with systemic hypertension. Am J Cardiol 2005;95(9):1060-4.PubMedPubMedCentralCrossRef Schneider RH, Alexander CN, Staggers F, et al. Long-term effects of stress reduction on mortality in persons > 55 years of age with systemic hypertension. Am J Cardiol 2005;95(9):1060-4.PubMedPubMedCentralCrossRef
15.
go back to reference Schneider R, Grim C, Rainforth M, et al. Stress reduction in the secondary prevention of cardiovascular disease: Randomized controlled trial of Transcendental Meditation and health education in Blacks. Circulation 2012;5:750-8.PubMed Schneider R, Grim C, Rainforth M, et al. Stress reduction in the secondary prevention of cardiovascular disease: Randomized controlled trial of Transcendental Meditation and health education in Blacks. Circulation 2012;5:750-8.PubMed
16.
go back to reference Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124(22):2458-73.PubMedCrossRef Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124(22):2458-73.PubMedCrossRef
17.
go back to reference Blumenthal JA, Sherwood A, Smith PJ, et al. Enhancing cardiac rehabilitation with stress management training: A randomized clinical efficacy trial. Circulation 2016;133(14):1341-50.PubMedPubMedCentralCrossRef Blumenthal JA, Sherwood A, Smith PJ, et al. Enhancing cardiac rehabilitation with stress management training: A randomized clinical efficacy trial. Circulation 2016;133(14):1341-50.PubMedPubMedCentralCrossRef
18.
go back to reference Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017;135(6):566-77.PubMedCrossRef Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017;135(6):566-77.PubMedCrossRef
19.
go back to reference Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131(1):19-27.PubMedCrossRef Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131(1):19-27.PubMedCrossRef
20.
go back to reference Blomster JI, Svedlund S, Westergren HU, et al. Coronary flow reserve as a link between exercise capacity, cardiac systolic and diastolic function. Int J Cardiol 2016;217:161-6.PubMedCrossRef Blomster JI, Svedlund S, Westergren HU, et al. Coronary flow reserve as a link between exercise capacity, cardiac systolic and diastolic function. Int J Cardiol 2016;217:161-6.PubMedCrossRef
21.
22.
go back to reference Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1-15.CrossRef Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1-15.CrossRef
23.
go back to reference Centers for Medicare and Medicaid Services. Proposed Decision Memo for Cardiac Rehabilitation Programs (CAG-00089R). 2006. Centers for Medicare and Medicaid Services. Proposed Decision Memo for Cardiac Rehabilitation Programs (CAG-00089R). 2006.
24.
go back to reference Sheps DS, McMahon RP, Becker L, et al. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation 2002;105(15):1780-4.PubMedCrossRef Sheps DS, McMahon RP, Becker L, et al. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation 2002;105(15):1780-4.PubMedCrossRef
25.
go back to reference Schindler TH, Quercioli A, Valenta I, et al. Quantitative assessment of myocardial blood flow-clinical and research applications. Semin Nucl Med 2014;44(4):274-93.PubMedCrossRef Schindler TH, Quercioli A, Valenta I, et al. Quantitative assessment of myocardial blood flow-clinical and research applications. Semin Nucl Med 2014;44(4):274-93.PubMedCrossRef
26.
go back to reference Gould KL, Johnson NP, Bateman TM, et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62(18):1639-53. Gould KL, Johnson NP, Bateman TM, et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62(18):1639-53.
27.
go back to reference Curb J, Labarthe D, Cooper S, et al. Training and certification of BP observers. Hypertension 1983;5:610-4.PubMedCrossRef Curb J, Labarthe D, Cooper S, et al. Training and certification of BP observers. Hypertension 1983;5:610-4.PubMedCrossRef
28.
go back to reference Beck A, Steer R, Brown G. BDI-II. Beck depression inventory. 2nd ed. San Antonio: The Psychological Corporation; 1996. Beck A, Steer R, Brown G. BDI-II. Beck depression inventory. 2nd ed. San Antonio: The Psychological Corporation; 1996.
29.
go back to reference American College of Sport Medicine. Guidelines for exercise testing and prescription. 7th ed. Philadelphia: Lea and Febiger; 2005. American College of Sport Medicine. Guidelines for exercise testing and prescription. 7th ed. Philadelphia: Lea and Febiger; 2005.
30.
go back to reference Orme-Johnson D, Walton K. All approaches to preventing or reversing effects of stress are not the same. Am J Health Promot 1998;12(5):297-9.PubMedCrossRef Orme-Johnson D, Walton K. All approaches to preventing or reversing effects of stress are not the same. Am J Health Promot 1998;12(5):297-9.PubMedCrossRef
32.
go back to reference Roth R. Strength in stillness: The power of transcendental meditation. New York: Simon and Schuster; 2018. Roth R. Strength in stillness: The power of transcendental meditation. New York: Simon and Schuster; 2018.
33.
go back to reference Rosenthal N. Transcendence: Healing and transformation through transcendental meditation. NYC: Penguin-Tarcher; 2011. Rosenthal N. Transcendence: Healing and transformation through transcendental meditation. NYC: Penguin-Tarcher; 2011.
34.
go back to reference Tijssen J, Kolm P. Demystifying the new statistical recommendations: The use and reporting of p values. J Am Coll Cardiol 2016;68(2):231-3.PubMedCrossRef Tijssen J, Kolm P. Demystifying the new statistical recommendations: The use and reporting of p values. J Am Coll Cardiol 2016;68(2):231-3.PubMedCrossRef
35.
36.
go back to reference Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124(20):2215-24.PubMedPubMedCentralCrossRef Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124(20):2215-24.PubMedPubMedCentralCrossRef
37.
go back to reference Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 2017;136(24):2325-36.PubMedPubMedCentralCrossRef Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 2017;136(24):2325-36.PubMedPubMedCentralCrossRef
38.
go back to reference Gunnoo T, Hasan N, Khan MS, et al. Quantifying the risk of heart disease following acute ischaemic stroke: A meta-analysis of over 50,000 participants. BMJ Open 2016;6(1):e009535.PubMedPubMedCentralCrossRef Gunnoo T, Hasan N, Khan MS, et al. Quantifying the risk of heart disease following acute ischaemic stroke: A meta-analysis of over 50,000 participants. BMJ Open 2016;6(1):e009535.PubMedPubMedCentralCrossRef
39.
go back to reference Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003;41(2):263-72.PubMedCrossRef Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003;41(2):263-72.PubMedCrossRef
40.
go back to reference Czernin J, Barnard RJ, Sun KT, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995;92(2):197-204.PubMedCrossRef Czernin J, Barnard RJ, Sun KT, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995;92(2):197-204.PubMedCrossRef
41.
go back to reference Yoshinaga K, Beanlands RS, Dekemp RA, et al. Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Am Heart J 2006;151(6):1324 e11-8. Yoshinaga K, Beanlands RS, Dekemp RA, et al. Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Am Heart J 2006;151(6):1324 e11-8.
42.
go back to reference Gould LK, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. J Am Med Assoc 1995;274:894-901.CrossRef Gould LK, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. J Am Med Assoc 1995;274:894-901.CrossRef
43.
go back to reference Zamarra JW, Schneider RH, Besseghini I, et al. Usefulness of the Transcendental Meditation program in the treatment of patients with coronary artery disease. Am J Cardiol 1996;78:77-80. Zamarra JW, Schneider RH, Besseghini I, et al. Usefulness of the Transcendental Meditation program in the treatment of patients with coronary artery disease. Am J Cardiol 1996;78:77-80.
44.
go back to reference Kallikazaros I, Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke 1999;30(5):1002-7.PubMedCrossRef Kallikazaros I, Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke 1999;30(5):1002-7.PubMedCrossRef
45.
go back to reference Nambi V, Pedroza C, Kao LS. Carotid intima-media thickness and cardiovascular events. Lancet 2012;379(9831):2028-30.PubMedCrossRef Nambi V, Pedroza C, Kao LS. Carotid intima-media thickness and cardiovascular events. Lancet 2012;379(9831):2028-30.PubMedCrossRef
46.
go back to reference Leucker TM, Valenta I, Schindler TH. Positron emission tomography-determined hyperemic flow, myocardial flow reserve, and flow gradient-quo vadis? Front Cardiovasc Med 2017;4:46.PubMedPubMedCentralCrossRef Leucker TM, Valenta I, Schindler TH. Positron emission tomography-determined hyperemic flow, myocardial flow reserve, and flow gradient-quo vadis? Front Cardiovasc Med 2017;4:46.PubMedPubMedCentralCrossRef
47.
go back to reference Ooi SL, Giovino M, Pak SC. Transcendental meditation for lowering blood pressure: An overview of systematic reviews and meta-analyses. Complement Ther Med 2017;34:26-34.PubMedCrossRef Ooi SL, Giovino M, Pak SC. Transcendental meditation for lowering blood pressure: An overview of systematic reviews and meta-analyses. Complement Ther Med 2017;34:26-34.PubMedCrossRef
48.
go back to reference Diamond GA, Kaul S. On reporting of effect size in randomized clinical trials. Am J Cardiol 2013;111(4):613-7.PubMedCrossRef Diamond GA, Kaul S. On reporting of effect size in randomized clinical trials. Am J Cardiol 2013;111(4):613-7.PubMedCrossRef
Metadata
Title
Effects of cardiac rehabilitation with and without meditation on myocardial blood flow using quantitative positron emission tomography: A pilot study
Authors
Sabahat Bokhari, MD, FACC
Robert H. Schneider, MD, FACC
John W. Salerno, PhD
Maxwell V. Rainforth, PhD
Carolyn Gaylord-King, PhD
Sanford I. Nidich, EdD
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-019-01884-9

Other articles of this Issue 4/2021

Journal of Nuclear Cardiology 4/2021 Go to the issue